相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes
J. Lin et al.
DIABETOLOGIA (2010)
Captopril and Combination Therapy of Captopril and Pentoxifylline in Reducing Proteinuria in Diabetic Nephropathy
Jamshid Roozbeh et al.
RENAL FAILURE (2010)
Altered Shear Stress Stimulates Upregulation of Endothelial VCAM-1 and ICAM-1 in a BMP-4-and TGF-β1-Dependent Pathway
Philippe Sucosky et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Serum Concentrations of Markers of TNF alpha and Fas-Mediated Pathways and Renal Function in Nonproteinuric Patients with Type 1 Diabetes
Monika A. Niewczas et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes
Elena Tarabra et al.
DIABETES (2009)
Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF-β1 enhanced IL-18 expression in human renal proximal tubular epithelial cells
Kazunari Miyauchi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
The MIF Receptor CD74 in Diabetic Podocyte Injury
Maria Dolores Sanchez-Nino et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Endothelial cell-selective adhesion molecule regulates albuminuria in diabetic nephropathy
Tetsuya Hara et al.
MICROVASCULAR RESEARCH (2009)
Correlation between Circulating Adhesion Molecule Levels and Albuminuria in Type-2 Diabetic Hypertensive Patients
Alberto Francisco Rubio-Guerra et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2009)
Effect of pentoxifylline on the evolution of diabetic nephropathy
Rafael Leyva-Jimenez et al.
MEDICINA CLINICA (2009)
Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy
Danqing Min et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-β, increases podocyte motility and albumin permeability
Eun Young Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
The effect of pentoxifylline on proteinuria in diabetic kidney disease: A meta-analysis
Brendan B. McCormick et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
Maria F. Lopes-Virella et al.
DIABETES CARE (2008)
Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
Julie Lin et al.
DIABETES CARE (2008)
The Role of chemokines and chemokine receptors in diabetic nephropathy
Christiane Ruster et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Expression of Alpha-actinin-4 in Human Diabetic Nephropathy
Moritsugu Kimura et al.
INTERNAL MEDICINE (2008)
The death ligand TRAIL in diabetic nephropathy
Corina Lorz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
The role of inflammatory cytokines in diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
Gang Jee Ko et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Defining human diabetic nephropathy on the molecular level: Integration of transcriptomic profiles with biological knowledge
Sebastian Martini et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2008)
Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats
Yuji Moriwaki et al.
ACTA DIABETOLOGICA (2007)
Role of macrophages in complications of type 2 diabetes
G. H. Tesch
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy
C. K. Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-α stimulation, and effects of a phosphodiesterase inhibitor
Nobuhiko Koike et al.
LIFE SCIENCES (2007)
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-κB activation
Sakiko Ohga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study
S. Araki et al.
DIABETOLOGIA (2007)
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice
F. Y. Chow et al.
DIABETOLOGIA (2007)
α-actinin-4 is required for normal podocyte adhesion
Savita V. Dandapani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Urinary tumour necrosis factor-α excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients
Juan F. Navarro et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
TNF-α activation of arterioles and venules alters distribution and levels of ICAM-1 and affects leukocyte-endothelial cell interactions
Ronen Sumagin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy
Holger Schmid et al.
DIABETES (2006)
How does proteinuria cause progressive renal damage?
Mauro Abbate et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
The effect of angiotensin II receptor blockade on an end-stage renal failure model of type 2 diabetes
Makoto Mizuno et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes -: Results from the Finnish diabetes prevention study
Christian Herder et al.
DIABETES (2006)
Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients
SS Soedamah-Muthu et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
Sang-Youb Han et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats
P Janiak et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Leukocyte recruitment and vascular injury in diabetic nephropathy
Elena Galkina et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice
FY Chow et al.
KIDNEY INTERNATIONAL (2006)
Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: Effect of angiotensin-converting enzyme inhibition and pentoxifylline administration
Juan F. Navarro et al.
AMERICAN JOURNAL OF NEPHROLOGY (2006)
Kidney diseases and chemokines
U Panzer et al.
CURRENT DRUG TARGETS (2006)
Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes
A Nakamura et al.
DIABETES CARE (2005)
Advanced glycation end-product induces fractalkine gene upregulation in normal rat glomeruli
Y Kikuchi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade:: A short-term, randomized, controlled trial
JF Navarro et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Nuclear factor-κB activation in diabetic rat kidney:: Evidence for involvement of P-selectin in diabetic nephropathy
M Iwamoto et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The next generation of diabetic nephropathy therapies: An update
ME Williams et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2005)
Mechanical stretch induces monocyte chemoattractant activity via an NF-κB-dependent monocyte chemoattractant protein-1-mediated pathway in inhibition by rosiglitazone human mesangial cells:: Inhibition by rosiglitazone
G Gruden et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes
M Dalla Vestra et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Comparative analysis of the renoprotective effects of pentoxifylline and vitamin E on streptozotocin-induced diabetes mellitus
ME Davila-Esqueda et al.
RENAL FAILURE (2005)
Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat
B Rodriguez-Iturbe et al.
KIDNEY INTERNATIONAL (2005)
Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis
T Wada et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Interleukin-18 enhances monocyte tumor necrosis factor α and interleukin-1β production induced by direct contact with T lymphocytes -: Implications in rheumatoid arthritis
SM Dai et al.
ARTHRITIS AND RHEUMATISM (2004)
Interactions between angiotensin II and NF-κB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy
FTH Lee et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology
G Wolf
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Blockade of CCR2 ameliorates progressive fibrosis in kidney
K Kitagawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure
A Cooper et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Fractalkine in vascular biology - From basic research to clinical disease
H Umehara et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Why is proteinuria an ominous biomarker of progressive kidney disease?
K Zandi-Nejad et al.
KIDNEY INTERNATIONAL (2004)
Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
F Chow et al.
KIDNEY INTERNATIONAL (2004)
Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys
Y Kikuchi et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2004)
Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats
K DiPetrillo et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
NF-κB activation and overexpression of regulated genes in human diabetic nephropathy
S Mezzano et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition
DT Bolick et al.
ENDOCRINOLOGY (2003)
Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes
S Okada et al.
DIABETES (2003)
Urinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic rats
K Kalantarinia et al.
KIDNEY INTERNATIONAL (2003)
Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor κB- and p38 mitogen-activated protein kinase-dependent pathways
R Donadelli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Effects of pentoxifylline administration on urinary N-acetyl-β-glucosaminidase excretion in type 2 diabetic patients:: A short-term, prospective, randomized study
JF Navarro et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1
B Amann et al.
DIABETES CARE (2003)
Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus
JF Navarro et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-α and Fas (CD95)
E Mariño et al.
CYTOKINE (2003)
Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus:: Relationship with diabetic nephropathy
Y Moriwaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes
K DiPetrillo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)
Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes
R Utimura et al.
KIDNEY INTERNATIONAL (2003)
Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy
T Morii et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2003)
Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes
RJL Stuyt et al.
IMMUNOLOGY (2003)
Expression of the fractalkine receptor (CX3CR1) in human kidney diseases
S Segerer et al.
KIDNEY INTERNATIONAL (2002)
A transmembrane tight junction protein selectively expressed on endothelial cells and platelets
I Nasdala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes - Progressive, interrelated, and independently associated with risk of death
CDA Stehouwer et al.
DIABETES (2002)
Abnormalities in primary granule exocytosis in neutrophils from Type I diabetic patients with nephropathy
NJM Fardon et al.
CLINICAL SCIENCE (2002)
Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy
K Tashiro et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2002)
Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy
ME Cooper
DIABETOLOGIA (2001)
Tissue-specific induction of E-selectin in glomeruli is augmented following diabetes mellitus
S Narumi et al.
NEPHRON (2001)
Extracellular signals and intracellular pathways in diabetic nephropathy
LY Chuang et al.
NEPHROLOGY (2001)
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure
VY Melnikov et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy
S Jones et al.
KIDNEY INTERNATIONAL (2001)
RANTES: a versatile and controversial chemokine
V Appay et al.
TRENDS IN IMMUNOLOGY (2001)
Transcription factor-κB (NF-κB) and renal disease
C Guijarro et al.
KIDNEY INTERNATIONAL (2001)
Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes
SC Thomson et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy
T Wada et al.
KIDNEY INTERNATIONAL (2000)
Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases
K Furuichi et al.
AMERICAN JOURNAL OF NEPHROLOGY (2000)
Increased spontaneous adherence of neutrophils from type 2 diabetic patients with overt proteinuria - Possible role of the progression of diabetic nephropathy
T Takahashi et al.
DIABETES CARE (2000)
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes
TM Coimbra et al.
KIDNEY INTERNATIONAL (2000)
Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate
R Nosadini et al.
DIABETES (2000)
Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats
C Sassy-Prigent et al.
DIABETES (2000)
分享论文
